The mental health system is failing millions of people. Patients cycle through medications that manage symptoms without addressing their source. Therapists reach ceilings that talk therapy alone cannot break through. Treatment-resistant depression, chronic PTSD, and anxiety disorders persist for years β sometimes decades β while the system offers little beyond dosage adjustments and waiting lists.
Meanwhile, a revolution is underway.
Clinical research at Johns Hopkins, NYU, UCSF, and through the MAPS clinical trial program has demonstrated that psychedelic-assisted therapy β using compounds including MDMA, psilocybin, and ketamine β can produce dramatic, lasting improvements in conditions that conventional treatments fail to resolve. Patients with chronic PTSD who had not responded to years of standard care no longer met diagnostic criteria after MDMA-assisted psychotherapy. A single psilocybin session reduced depression and anxiety in cancer patients for months. Ketamine-assisted psychotherapy is producing rapid relief for treatment-resistant depression in clinics across the country right now.
Will Van Derveer, MD, and Keith Kurlander, MA, LPC β co-founders of the Integrative Psychiatry Institute and authors of Psychedelic Therapy: A Revolutionary Approach to Restoring Your Mental Health and Reclaiming Your Life β stand at the forefront of this shift. Van Derveer served as co-investigator on MAPS-sponsored MDMA clinical trials for treatment-resistant PTSD. He provides ketamine-assisted psychotherapy at his integrative psychiatry practice in Boulder, Colorado. Together with Kurlander, he has trained thousands of mental health professionals in the integrative, root-cause approach to psychiatric care that psychedelic therapy demands.
This companion guide makes their work accessible, actionable, and deeply practical.
Whether you are considering psychedelic therapy for yourself, supporting a loved one through the process, or seeking professional development as a mental health provider, this book equips you with everything you need to engage with this field from a position of knowledge rather than confusion.
Inside you will find:
A clear explanation of why conventional psychiatry struggles with treatment-resistant conditions β and how unresolved trauma operates as the hidden driver of most psychiatric suffering.
The neuroscience of how psychedelic compounds actually work β neuroplasticity, default mode network disruption, serotonin pathways, and amygdala modulation explained in accessible, precise terms.
Detailed profiles of the major compounds β MDMA, psilocybin, ketamine, ayahuasca, mescaline, LSD, and ibogaine β including pharmacology, clinical evidence, legal status, and safety considerations for each.
A complete walkthrough of the therapeutic process β from preparation and intention setting through the medicine session itself and into the integration work that determines whether session gains become lasting change.
Honest assessment of the risks β medical contraindications, psychological vulnerabilities, medication interactions, and the critical distinction between clinical treatment and recreational use.
A practical framework for finding qualified practitioners β including what credentials to verify, what questions to ask, what red flags to watch for, and how to navigate the current legal landscape of clinical trials, state psilocybin programs, and ketamine clinics.
The future of the field β regulatory pathways, the tension between access and quality, and Van Derveer and Kurlander's vision for a mental health system designed to heal rather than manage.
This Book Includes:
β Practical Exercises β Key Insights β Action Plan β Key Concepts
Every chapter features reflection exercises, application exercises, key insight boxes, key concept summaries with glossary references, and concrete action steps β transforming this guide from a passive reading experience into a working tool for informed decision-making and pers
Psychedelic Therapy and Will Van Derveer's Research - Kevin Essentials
The mental health system is failing millions of people. Patients cycle through medications that manage symptoms without addressing their source. Therapists reach ceilings that talk therapy alone cannot break through. Treatment-resistant depression, chronic PTSD, and anxiety disorders persist for years β sometimes decades β while the system offers little beyond dosage adjustments and waiting lists.
Meanwhile, a revolution is underway.
Clinical research at Johns Hopkins, NYU, UCSF, and through the MAPS clinical trial program has demonstrated that psychedelic-assisted therapy β using compounds including MDMA, psilocybin, and ketamine β can produce dramatic, lasting improvements in conditions that conventional treatments fail to resolve. Patients with chronic PTSD who had not responded to years of standard care no longer met diagnostic criteria after MDMA-assisted psychotherapy. A single psilocybin session reduced depression and anxiety in cancer patients for months. Ketamine-assisted psychotherapy is producing rapid relief for treatment-resistant depression in clinics across the country right now.
Will Van Derveer, MD, and Keith Kurlander, MA, LPC β co-founders of the Integrative Psychiatry Institute and authors of Psychedelic Therapy: A Revolutionary Approach to Restoring Your Mental Health and Reclaiming Your Life β stand at the forefront of this shift. Van Derveer served as co-investigator on MAPS-sponsored MDMA clinical trials for treatment-resistant PTSD. He provides ketamine-assisted psychotherapy at his integrative psychiatry practice in Boulder, Colorado. Together with Kurlander, he has trained thousands of mental health professionals in the integrative, root-cause approach to psychiatric care that psychedelic therapy demands.
This companion guide makes their work accessible, actionable, and deeply practical.
Whether you are considering psychedelic therapy for yourself, supporting a loved one through the process, or seeking professional development as a mental health provider, this book equips you with everything you need to engage with this field from a position of knowledge rather than confusion.
Inside you will find:
A clear explanation of why conventional psychiatry struggles with treatment-resistant conditions β and how unresolved trauma operates as the hidden driver of most psychiatric suffering.
The neuroscience of how psychedelic compounds actually work β neuroplasticity, default mode network disruption, serotonin pathways, and amygdala modulation explained in accessible, precise terms.
Detailed profiles of the major compounds β MDMA, psilocybin, ketamine, ayahuasca, mescaline, LSD, and ibogaine β including pharmacology, clinical evidence, legal status, and safety considerations for each.
A complete walkthrough of the therapeutic process β from preparation and intention setting through the medicine session itself and into the integration work that determines whether session gains become lasting change.
Honest assessment of the risks β medical contraindications, psychological vulnerabilities, medication interactions, and the critical distinction between clinical treatment and recreational use.
A practical framework for finding qualified practitioners β including what credentials to verify, what questions to ask, what red flags to watch for, and how to navigate the current legal landscape of clinical trials, state psilocybin programs, and ketamine clinics.
The future of the field β regulatory pathways, the tension between access and quality, and Van Derveer and Kurlander's vision for a mental health system designed to heal rather than manage.
This Book Includes:
β Practical Exercises β Key Insights β Action Plan β Key Concepts
Every chapter features reflection exercises, application exercises, key insight boxes, key concept summaries with glossary references, and concrete action steps β transforming this guide from a passive reading experience into a working tool for informed decision-making and pers